Cargando…
Inhibitors of Endocannabinoids’ Enzymatic Degradation as a Potential Target of the Memory Disturbances in an Acute N-Methyl-D-Aspartate (NMDA) Receptor Hypofunction Model of Schizophrenia in Mice
Treating schizophrenia with the available pharmacotherapy is difficult. One possible strategy is focused on the modulation of the function of the endocannabinoid system (ECS). The ECS is comprised of cannabinoid (CB) receptors, endocannabinoids and enzymes responsible for the metabolism of endocanna...
Autores principales: | Kruk-Slomka, Marta, Adamski, Bartlomiej, Slomka, Tomasz, Biala, Grazyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380236/ https://www.ncbi.nlm.nih.gov/pubmed/37511157 http://dx.doi.org/10.3390/ijms241411400 |
Ejemplares similares
-
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review
por: Kruk-Slomka, Marta, et al.
Publicado: (2016) -
Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice
por: Kruk-Slomka, Marta, et al.
Publicado: (2019) -
The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801
por: Kruk-Slomka, Marta, et al.
Publicado: (2016) -
Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice
por: Kruk-Slomka, Marta, et al.
Publicado: (2021) -
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
por: Kruk-Slomka, Marta, et al.
Publicado: (2016)